Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126913831 | 12691383 | 1 | I | 20160527 | 20160826 | 20160826 | EXP | US-ASTRAZENECA-2016SE58481 | ASTRAZENECA | 0.00 | M | Y | 0.00000 | 20160826 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126913831 | 12691383 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | U | 206995 | 250 | MG | TABLET | QD | ||||||
126913831 | 12691383 | 2 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
126913831 | 12691383 | 3 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
126913831 | 12691383 | 4 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
126913831 | 12691383 | 5 | C | ALEVE | NAPROXEN SODIUM | 1 | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126913831 | 12691383 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126913831 | 12691383 | Death | |
126913831 | 12691383 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126913831 | 12691383 | 1 | 20160505 | 0 |